Review of a psychiatric outpatient therapy program using ketamine across different diagnoses

Ian Stefanuk has provided psychiatric consultation for patients seen at the Newly Institute since 2023. Kaitlin Chivers-Wilson was a medical advisor to the Newly Institute from 2021 to 2023. Rakesh Jetly was a medical advisor to the Newly Institute from 2021 to 2023. Atul Khullar was a medical advisor to the Newly Institute from 2021 to 2023 and has received honoraria for speaking or advising for Elvium, the Collaborative Continuing Education and Research Network, the International Center for Professional Development in Health and Medicine, Lundbeck, Otsuka, Takeda, Eisai, Idorsia, Bausch, Abbvie, Pfizer, Sunovion, and Spectrum. Robert Tanguay has received honoraria for speaking from the International Foundation of Employee Benefit Plans, Recovery Capital Conference of Canada, Alberta Association of Pharmacists, Medavie Blue Cross, the Newly Institute, Queen’s University, and Clackamas County and for speaking and advising from the Master Clinician Alliance. He attended an unpaid advisory board and moderated a lunch symposium at the Canadian Society for Addiction Medicine meeting for Indivior, is the founder and shareholder of the Newly Institute, and was previously its chief medical officer. Yanbo Zhang has no disclosures. Jennifer Swainson has received honoraria for speaking or advising from AbbVie, Bausch, Biron, Eisai, Idorsia, Janssen, Lundbeck, Otsuka, and Novonordisk. Swainson was medical advisor to the Newly Institute from 2021 to 2023.